-
Mashup Score: 0Webinar Recording: 2022 ICD-10-CM Coding Updates - 2 year(s) ago
MedAxiom is one of the most valuable resources a cardiology practice can have. We are a comprehensive subscription-based service provider and information resource exclusively for cardiology practices.
Source: MedAxiomCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Factors Associated With Racial and Ethnic Diversity Among Heart Failure Trial Participants: A Systematic Bibliometric Review - 2 year(s) ago
Background: Heart failure has a disproportionate burden on patients who are Black, Indigenous, and people of color (BIPOC), but not much is known about representation of these groups in randomized co
Source: Circulation: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet-
Gratitude to our collaborators @KBreathettMD @SJGreene_md @mmamas1973 @FaiezZANNAD for input, advice, support on this and other projects. 🙏🏽 @ilppina, reviewers, #BridgetteCain from production team (who’s always a delight). https://t.co/Gv4w4O3igl https://t.co/cKd7gXI8Go
-
Why does #representativeness in #RCTs matter? What can we do to address underrepresentation of demographic groups who live with #CVD?👇🏽 https://t.co/Gv4w4O3igl Geographic inclusion matters too, a 🔑 to increasing #racial #ethnic #diversity in #RCTs https://t.co/gq5KvYIjTp https://t.co/F6g0wsU8tf
-
📍 enrolment of #BIPOC participants increased by 0.6% each year 📍 after multivariable adjustment, trial leadership by a woman was associated with 8.4% ⬆️ enrolment of BIPOC participants (other trial factors had no association) https://t.co/Gv4w4O3igl @PeterPLiu_MD @Drroxmehran https://t.co/8VPNHq1KjE
-
Factors independently associated with reporting #race/#ethnicity data in #HeartFailure #RCTs included 📍multi-center, multi-country enrolment 📍industry funding 📍trial leadership by a woman https://t.co/Gv4w4O3igl @HeartOTXHeartMD https://t.co/SJQ2WzEfmr
-
Among the 38% #RCTs reporting #race / #ethnicity data, only 📍24% reported how these data were obtained 📍56% specified race/ethnicity categories 📍20% performed subgroup analysis 📍8% tested for treatment interaction https://t.co/Gv4w4O3igl #reporting @drdargaray @ErinMichos https://t.co/UdqDHRmeqH
-
Proud of #SunnyWei @NhatChinhLe @zhennyju for @CircHF📄 on #racial #ethnic #diversity among participants in #HF #RCTs 2000-2020 📍<38% of 414 RCTs reported race/ethnicity data 📍<19% were #BIPOC participants (underrepresented) 📍Trends improved w/ time https://t.co/Gv4w4O3igl https://t.co/rfnpk76Hfd
-
-
Mashup Score: 1
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a drug-induced severe cutaneous adverse reaction that is often overlooked owing to its overlap with other infectious and inflammatory illnesses; however, early identification and treatment are important to preventing associated morbidity and mortality.1,2 Historically, anticonvulsant use in association with DRESS syndrome was cited…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! Reporting of #drug #reaction with #eosinophilia and #systemic #symptoms from 2002 to 2019 in the #US #Food and #Drug #Administration #Adverse #Event #Reporting #System https://t.co/iPEyeg0Qu8 https://t.co/ZnruYwv0FE
-
-
Mashup Score: 0Reporting of Drug Reaction with Eosinophilia and Systemic Symptoms from 2002-2019 in the FDA Adverse Event Reporting System (FAERS) - 3 year(s) ago
Article InfoPublication HistoryAccepted: May 4, 2021Received in revised form: May 3, 2021Received: February 24, 2021Publication stageIn Press Journal Pre-ProofFootnotesDisclosures:EJP reports grants from National Institutes of Health (P50GM115305, R01HG010863, R01AI152183, R21AI139021, U01AI154659) and from the National…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! Reporting of #Drug #Reaction with #Eosinophilia and #Systemic #Symptoms from 2002-2019 in the #FDA #Adverse #Event #Reporting #System ( #FAERS) https://t.co/iPEyeg0Qu8
-
-
Mashup Score: 0Public reporting of outcomes in radiation oncology: the National Prostate Cancer Audit - 3 year(s) ago
The public reporting of patient outcomes is crucial for quality improvement and informing patient choice. However, outcome reporting in radiotherapy, despite being a major component of cancer control, is extremely sparse globally. Public reporting has many challenges, including difficulties in defining meaningful measures of treatment quality, limitations in data infrastructure, and fragmented…
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
May issue Personal View: Public #reporting of #outcomes in #radiationoncology: the National #ProstateCancer Audit #radonc #pcsm https://t.co/j5pqoOJs1x
-
-
Mashup Score: 0Public reporting of outcomes in radiation oncology: the National Prostate Cancer Audit - 3 year(s) ago
The public reporting of patient outcomes is crucial for quality improvement and informing patient choice. However, outcome reporting in radiotherapy, despite being a major component of cancer control, is extremely sparse globally. Public reporting has many challenges, including difficulties in defining meaningful measures of treatment quality, limitations in data infrastructure, and fragmented…
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
NEW Personal View: Public #reporting of #outcomes in #radiationoncology: the National #ProstateCancer Audit #radonc #pcsm https://t.co/j5pqoOrR9Z
-
-
Mashup Score: 0Reporting cancer care outcomes from the private sector - 4 year(s) ago
The split between public and private cancer care in the UK is not straightforward. The UK National Health Service (NHS) is free at the point of delivery, but NHS hospitals also provide private care and independent hospitals care for NHS patients. Indeed, 2020 has seen a great deal of cancer care locally transferred from public hospitals to private ones, so as to allow the NHS to focus on the…
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
News: #Reporting #cancer care #outcomes from the #privatesector https://t.co/E6pYrNVdvB
-
-
Mashup Score: 5Emerging Causes of Drug–Induced Anaphylaxis: A Review of Anaphylaxis–Associated Reports in the FDA Adverse Event Reporting System (FAERS) - 4 year(s) ago
Drug induced anaphylaxis is a well-known adverse drug reaction for some drug classes, but emerging drug causes of anaphylaxis and novel mechanisms may contribute in unrecognized ways.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! Emerging Causes of #Drug– #Induced #Anaphylaxis: A Review of #Anaphylaxis–#Associated #Reports in the #FDA #Adverse #Event #Reporting #System ( #FAERS) https://t.co/0CRfySYmRl
-
-
Mashup Score: 0Ikonopedia, Qlarity partner on breast cancer reporting - 4 year(s) ago
Breast imaging software developer Ikonopedia and medical artificial intelligence developer Qlarity Imaging have teamed up to advance breast cancer diagnosis and reporting.
Source: AuntMinnie.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@ikonopedia @QlarityImaging partner on #breastcancer #reporting | #AI #radiology https://t.co/LG12REo2mu
-
-
Mashup Score: 2Clinical characterization and diagnostic approaches for patients reporting hypersensitivity reactions to quinolones - 4 year(s) ago
Quinolones are the second most frequent cause of hypersensitivity reactions (HSRs) to antibiotics. A marked increase in the number of patients with HSRs to quinolones has been detected.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! #Clinical #characterization and #diagnostic #approaches for #patients #reporting #hypersensitivity reactions to #quinolones https://t.co/61mxlUmGsj https://t.co/rv33AvxJN6
-
Take a dive deep into the complexity of diagnosis coding. In this webinar, experts review the ICD-10-CM official guidelines for #coding and #reporting. We also revisit the importance of risk adjustment coding and how this can impact your organization. https://t.co/JupIZPzTJy https://t.co/1o9KdAi8Yq